Sudapyridine (WX-081) in RR-TB Patients

Condition:   Rifampicin-resistant Tuberculosis Interventions:   Drug: Sudapyridine;   Drug: Bedaquiline Sponsor:   Shanghai Jiatan Pharmatech Co., Ltd Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials